Appropriate Systemic Therapy Dosing for Obese Adult Patients with Cancer

Publication Date: April 26, 2021

Key Points

Key Points

  • The Panel continues to recommend that full, weight-based cytotoxic chemotherapy doses be used to treat obese adults with cancer.
  • The Panel also recommends that full, approved doses of immunotherapy and targeted therapies be offered to obese adults with cancer.
  • In the event of toxicity, the consensus of the Panel is that dose modifications of systemic antineoplastic therapies should be handled similarly for obese and non-obese patients.

Treatment

Treatmen...

...weight-based dosing of cytotoxic chemothera...


...mmends limiting fixed dosing of che...


...DA-approved prescribing information for checkpoin...


...prescribing information for targeted...


...ent experiences high-grade toxicity...


...anel recommends that BSA be calculated using...